Castelion Raises $1B Series C at $13B Valuation

Castelion just raised $1 billion at a $13 billion valuation, and the round tells you more about where venture capital is heading in 2026 than almost any AI deal this month. This is a four-year-old missile company, founded by ex-SpaceX engineers, that JPMorgan Chase and a public-markets crossover fund just helped fund alongside two of the most storied names in tech venture capital.

Defense tech has been the quiet growth story of this venture cycle, sitting next to AI infrastructure rather than competing with it for headlines. Castelion's Series C — announced August 26, 2026 — is now one of the largest rounds any venture-backed defense manufacturer has ever closed, and it arrived less than four years after the company's founding.

What is Castelion's valuation in 2026?

Castelion is valued at $13 billion as of its Series C round, which closed and was announced on August 26, 2026. The round was co-led by three very different types of capital — Andreessen Horowitz (venture), Carlyle (private equity), and JPMorgan Chase (a bank's direct investing arm) — a combination that signals institutional capital now treats defense manufacturing as a durable, fundable category rather than a niche venture bet.

The jump matters as much as the number. Castelion was founded in 2022 and has already secured more than $500 million in U.S. military contracts, but this Series C represents a step-change in how the company is capitalized — moving from venture-scale checks to a financing structure built for industrial-scale manufacturing.

How is the $1 billion round structured?

Castelion's Series C combines $800 million in traditional equity financing with $250 million in committed financing for a revolving credit facility. That structure — part equity, part debt facility — is unusual for a venture round and is more typical of growth-stage industrial companies that need working capital to fund inventory, tooling, and factory buildout alongside pure R&D spend. It's a strong signal that this capital is earmarked for scaling physical production, not just extending runway.

Who are Castelion's investors?

The round was co-led by Andreessen Horowitz, Carlyle, and JPMorgan Chase. Additional participants included Lightspeed Venture Partners, Lavrock Ventures, Altimeter Capital, General Catalyst, and Interlagos. T. Rowe Price Associates joined as a first-time backer, notable because T. Rowe is primarily a public-markets asset manager — its participation in a private Series C is the kind of crossover-fund move that typically shows up ahead of an eventual IPO, not four years into a company's life.

Carlyle's involvement is also worth flagging on its own: a private equity firm known for buyouts and infrastructure deals co-leading a venture-style Series C reflects how blurred the line between "growth venture" and "private equity" has become in capital-intensive sectors like defense manufacturing, where checks need to fund factories, not just software.

What does Castelion actually build?

Castelion's flagship product is Blackbeard, a low-cost, mass-producible hypersonic strike missile. The company's core thesis, set by its SpaceX-alumni founding team, is that hypersonic weapons can be manufactured at aerospace-manufacturing scale and speed rather than hand-built in small, expensive batches the way traditional defense primes like Lockheed Martin and Raytheon have historically built munitions. The new capital will fund an expanded product portfolio — longer-range strike weapons and defensive systems — alongside a major buildout of Castelion's Project Ranger campus in Sandoval County, New Mexico, a 1,000-acre site the company describes as the largest dedicated hypersonic missile manufacturing facility in the United States.

What the headline misses

A $13 billion valuation on a company with roughly $500 million in disclosed military contracts is pricing in a lot of future defense procurement that hasn't happened yet. Government contracting timelines are notoriously slow and politically contingent, and mass-producible hypersonic weapons remain a technically unproven category at true production scale — Castelion's Blackbeard program still has to prove it can hit the manufacturing throughput and unit-cost targets that justify the "low-cost, mass-producible" pitch investors are underwriting. The $250 million credit facility component also means part of this round is debt, not equity, which changes how the company's balance sheet — and its downside risk — actually looks.

Why does this round matter for venture capital in 2026?

Castelion's raise is a data point in a broader 2026 pattern: defense tech and physical-manufacturing startups are pulling in the kind of megaround capital that used to be reserved almost exclusively for frontier AI labs. When a16z, Carlyle, and JPMorgan co-lead the same check, and a public-markets crossover fund like T. Rowe Price shows up as a first-time backer, it means institutional capital has stopped treating "defense manufacturing startup" as a specialty allocation and started treating it as a core growth category — alongside AI infrastructure and grid-flexibility plays that raised comparably large rounds earlier this same month.